Overview:
Organ transplant placement of healthy organ from donor site to replace a damaged or absent organ.Human leukocyte antigens a histocompatibility complex are found on cell surface that regulates adopting of replaced organ. Human leukocyte diagnostic testing (HLA testing/test) is performed foe determination of tissue compatibility between recipient and donor. HLA matching augments graft survival possibility and reduces transplant rejection and failure.
Increasing pool of geriatric population, incidence of chronic diseases leading to organ failure are the major drivers of transplant diagnostics market. However, high costs of transplant procedures and a wide gap in the donor and waiting list, and restrained reimbursement may hold back the growth of this market. Geographically, North America is the largest market for transplant diagnostics followed by Europe. However, trends such as medical tourism, and growing awareness and healthcare expenditure will drive the Asia Pacific and Middle East markets at over than global average growth rate.
The global transplant diagnostics market is segmented on the following bases:
Key players identified for transplant diagnostics market include but are not limited to:
Qiagen N.V., Sigma-Aldrich, Olerup Ssp Ab, F. Hoffmann-La Roche, Thermo Fisher Scientific, Inc., Illumina, Inc., Abbott Laboratories, Inc., Immucor Transplant Diagnostics, Inc., Bio-Rad Laboratories, Inc., Omixon Ltd., Luminex Corporation , and severalothers
This report offers:
